家畜用ワクチンの世界市場

家畜用ワクチンの世界市場は2030年までに79億米ドルに到達

2024年に59億米ドルと推定される家畜用ワクチンの世界市場は、2024年から2030年にかけてCAGR 5.0%で成長し、2030年には79億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである牛ワクチンは、CAGR 3.5%を記録し、分析期間終了時には28億米ドルに達すると予測されます。家禽ワクチン分野の成長率は、分析期間中CAGR 6.1%と推定されます。

米国市場は16億米ドルと推定、中国はCAGR 7.6％で成長予測

米国の家畜用ワクチン市場は、2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに15億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.5％と4.9％と予測されています。欧州では、ドイツがCAGR 3.2%で成長すると予測されています。

世界の家畜用ワクチン市場- 主要動向と促進要因のまとめ

家畜用ワクチンが世界の食糧安全保障と人獣共通感染症対策において戦略的重要性を増している理由とは？

家畜用ワクチンは、世界の公衆衛生、食糧供給の安定性、そして農業を基盤とする経済における経済的回復力において、重要なツールとして認識されつつあります。タンパク質需要の増加、都市化、食生活の嗜好の変化などを背景とした畜産の激化は、家畜集団における風土病、伝染病、新興感染症のリスクを高めています。ワクチン接種は、ウシ、ニワトリ、ブタ、ヤギ、その他の畜産動物の罹患率や死亡率を予防するための、効果的で拡張性があり、多くの場合費用効率の高い方法です。口蹄疫（FMD）、アフリカ豚コレラ熱（ASF）、鳥インフルエンザ、ブルセラ症など、国境を越えた動物疾病の脅威に各国が対処する中、家畜用ワクチンは国の疾病撲滅・封じ込め戦略に不可欠なものとなっています。

家畜用ワクチンは、動物の健康に直接役立つだけでなく、人間の健康やバイオセキュリティーにも多大な影響を及ぼします。人獣共通感染症病原体は、ヒトの新興感染症のかなりの割合を占めており、その多くは管理の不十分な、あるいはワクチン接種を受けていない動物集団から発生しています。ワクチン接種は宿主の病原体保有量を減少させ、感染サイクルを遮断し、公衆衛生を守る。さらに、予防接種は畜産における抗生物質への依存を減らし、現在、世界の健康上の重要な課題とみなされている抗菌薬耐性（AMR）を緩和するための世界の取り組みを支援します。このような動物、人間、環境の健康の相互作用により、ワクチンはワンヘルスの枠組みの礎石として確固たる地位を築いています。

科学的革新と製造技術はどのようにワクチン開発を形成しているのか？

分子生物学、ゲノム学、免疫学の急速な進歩は、家畜ワクチン開発に革命をもたらし、より正確で、より迅速で、スケーラブルなソリューションを可能にしています。組換えDNA技術、サブユニットワクチン、ベクターベースのプラットフォーム、不活化ウイルスキャリアは、病原性復帰や副作用のリスクを低減した、より安全で効果的なワクチンの開発に使用されています。これらのアプローチは、特定の抗原を標的とし、異なる種や病原体株に対する免疫応答を調整することを可能にします。ヒトのmRNAワクチンの成功に倣ったRNAベースのワクチンや遺伝子欠失ワクチンは、パンデミック規模の開発をより迅速に行うために現在研究中です。

これと並行して、ワクチンの送達技術も飛躍的に向上しています。耐熱性製剤の技術革新により、コールドチェーン物流が困難な遠隔地やインフラの乏しい地域でも、より広範囲にワクチンを浸透させることが可能になっています。ニードルフリー注射器、経口ベイト剤、経皮パッチ、経鼻スプレーは、投与を簡素化し、動物のストレスを軽減するために試験的に使用されています。特定の牛群やアウトブレイク用にカスタマイズされた自家ワクチンも、特に病原体の変異が激しかったり、地域的な風土病が蔓延している地域では、人気を集めています。連続生産ライン、バイオリアクターベースの抗原合成、モジュール式の充填・仕上げプラットフォームなど、製造のアップグレードは、スケーラビリティを向上させ、日常的なワクチン配備と緊急時のワクチン配備の両方のリードタイムを短縮しています。

規制の枠組み、貿易圧力、畜産経済が市場進化に果たす役割とは？

家畜用ワクチン市場は、規制のハーモナイゼーション、動物衛生サーベイランス、貿易主導のバイオセーフティ・コンプライアンスの影響を強く受けています。OIE（現WOAH）、欧州医薬品庁（EMA）、米国農務省（USDA）などの獣医学的規制機関は、ワクチンの品質、有効性、市販後調査に関するガイドラインを提供し、動物福祉を守りつつ技術革新を支援する構造化された環境を作り出しています。規制の枠組みは、新規ワクチン・プラットフォーム、アウトブレイク時の条件付き承認、緊急事態のための迅速承認などにますます対応するようになってきており、商業化の道筋や官民の協力体制を加速させている要因となっています。

国際貿易力学は、家畜ワクチン接種の重要性をさらに高めています。生きた家畜、食肉、乳製品を輸出する国は、厳格な動物衛生証明や無病宣言に従わなければならないが、これらの証明は効果的な予防接種プロトコルにかかっています。例えば、ワクチン接種の有無にかかわらず、FMD無発病のステータスは高価値輸出市場へのアクセスを左右します。ワクチンの遵守は、補助金や家畜保険、家畜移動許可証の取得にも不可欠です。生産者レベルでは、飼料コスト、気候変動、市場の変動に関連する経済的圧力が、ワクチン接種による疾病予防を、治療や淘汰に基づくアプローチよりも魅力的なものにしています。

家畜用ワクチン市場の世界的拡大の原動力は？

家畜用ワクチン市場の成長は、いくつかのマクロ経済的、技術的、政策的要因によって牽引されています。最も顕著な促進要因のひとつは、タンパク質が豊富な食生活と集約的畜産への世界の食糧システムの構造的転換です。この転換は特にアジア、ラテンアメリカ、アフリカの一部で顕著であり、そこでは所得の上昇と都市化が鶏肉、牛肉、乳製品の需要に拍車をかけています。こうした需要に持続的に応えるため、生産者は死亡率を減らし、飼料効率を高め、牛群全体の生産性を向上させるワクチン接種プログラムに投資しています。

低・中所得国では、政府主催の集団予防接種プログラム、パンデミック対策戦略、ドナー支援による獣医へのアウトリーチが、ワクチン接種率と需要をさらに拡大しています。FAOや世界銀行のような組織による獣医学的インフラや疾病監視システムの構築のための取り組みも、ワクチン導入に向けた地域の準備態勢を高めています。デジタル動物衛生プラットフォームはワクチン追跡、有害事象報告、コールドチェーン監視をサポートし、モバイルベースの家畜衛生サービスは小農や遊牧民へのアウトリーチを向上させています。

民間セクターの関与も高まっています。多国籍製薬企業の動物衛生部門は、ワクチン・ポートフォリオを拡大し、現地メーカーを買収し、地域の研究開発センターに投資しています。これと並行して、合成生物学や微生物を利用したワクチンに関する新興企業の活動も活発化しており、種特異的で精密な予防接種に新たなフロンティアが開かれつつあります。これらの力が相互に作用し続けることで、世界の家畜用ワクチン市場は、規模だけでなく戦略的関連性においても成長し、動物の生産性、経済の回復力、公衆衛生の安全性を確保する態勢が整っています。

セグメント

ワクチンタイプ（牛ワクチン、家禽ワクチン、豚ワクチン、その他のワクチンタイプ）、技術（生ワクチン技術、不活化ワクチン技術、遺伝子組換えワクチン技術、その他の技術）、投与経路（経口投与経路、非経口投与経路、その他の投与経路）、エンドユーザー（動物病院エンドユーザー、動物病院エンドユーザー、その他のエンドユーザー）

調査対象企業の例（注目の計42社）

• ADL Bionatur Solutions, S.A.
• AniCon Labor GmbH
• Animal Science Products Inc.
• Bayer AG
• Bimeda Biologicals
• Biogenesis Bago
• Boehringer Ingelheim Animal Health
• Calier
• Cargill Incorporated
• Ceva Sante Animale
• China Animal Husbandry Industry Co.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health
• Hester Biosciences Limited
• HIPRA
• Indovax
• Merck Animal Health
• Neogen Corporation
• Phibro Animal Health Corporation
• Zoetis Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Livestock Vaccines Market to Reach US$7.9 Billion by 2030

The global market for Livestock Vaccines estimated at US$5.9 Billion in the year 2024, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bovine Vaccine, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Poultry Vaccine segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 7.6% CAGR

The Livestock Vaccines market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Livestock Vaccines Market - Key Trends & Drivers Summarized

Why Are Livestock Vaccines Gaining Strategic Importance in Global Food Security and Zoonotic Disease Control?

Livestock vaccines are increasingly recognized as critical tools in global public health, food supply stability, and economic resilience in agriculture-based economies. The intensification of animal farming-driven by growing protein demand, urbanization, and shifting dietary preferences-has elevated the risk of endemic, epidemic, and emerging infectious diseases among livestock populations. Vaccination offers an effective, scalable, and often cost-efficient method for preventing morbidity and mortality in cattle, poultry, swine, goats, and other farmed animals. As countries grapple with the threat of transboundary animal diseases such as foot-and-mouth disease (FMD), African swine fever (ASF), avian influenza, and brucellosis, livestock vaccines are becoming integral to national disease eradication and containment strategies.

Beyond direct animal health benefits, livestock vaccines have far-reaching implications for human health and biosecurity. Zoonotic pathogens account for a significant proportion of emerging infectious diseases in humans, many of which originate in poorly managed or unvaccinated animal populations. Vaccination reduces pathogen load in reservoir hosts, interrupting transmission cycles and safeguarding public health. Moreover, immunization reduces reliance on antibiotics in animal husbandry, supporting global efforts to mitigate antimicrobial resistance (AMR), which is now regarded as a critical global health challenge. These intersections between animal, human, and environmental health have cemented vaccines as a cornerstone of the One Health framework.

How Are Scientific Innovations and Manufacturing Technologies Reshaping Vaccine Development?

Rapid advancements in molecular biology, genomics, and immunology are revolutionizing livestock vaccine development, enabling more precise, faster, and scalable solutions. Recombinant DNA technology, subunit vaccines, vector-based platforms, and inactivated virus carriers are being used to develop safer and more effective vaccines with reduced risk of virulence reversion or side effects. These approaches allow for the targeting of specific antigens and the tailoring of immune responses to different species and pathogen strains. RNA-based and gene-deletion vaccines, modeled on human mRNA vaccine success, are under exploration for faster pandemic-scale development.

In parallel, vaccine delivery technologies are improving dramatically. Innovations in thermostable formulations are enabling wider vaccine penetration in remote or infrastructure-poor regions where cold chain logistics are challenging. Needle-free injectors, oral baits, transdermal patches, and intranasal sprays are being piloted to simplify administration and reduce animal stress. Autogenous vaccines-customized for specific herds or outbreaks-are also gaining traction, particularly in regions where pathogens mutate rapidly or are locally endemic. Manufacturing upgrades, including continuous production lines, bioreactor-based antigen synthesis, and modular fill-and-finish platforms, are improving scalability and reducing lead times for both routine and emergency vaccine deployment.

What Role Do Regulatory Frameworks, Trade Pressures, and Livestock Economics Play in Market Evolution?

The livestock vaccines market is strongly influenced by regulatory harmonization, animal health surveillance, and trade-driven biosafety compliance. Veterinary regulatory agencies, including the OIE (now WOAH), EMA, and USDA, provide guidelines for vaccine quality, efficacy, and post-market surveillance, creating a structured environment that supports innovation while safeguarding animal welfare. Regulatory frameworks are increasingly accommodating novel vaccine platforms, conditional licensure during outbreaks, and fast-track approval for emergency situations-factors that are accelerating commercialization pathways and public-private collaborations.

International trade dynamics further amplify the importance of livestock vaccination. Countries exporting live animals, meat, or dairy products must comply with stringent animal health certifications and disease-free declarations, which hinge on effective immunization protocols. For instance, FMD-free status with or without vaccination determines market access to high-value export markets. Vaccine compliance is also critical in obtaining subsidies, livestock insurance, and access to livestock movement permits. At the producer level, economic pressures related to feed costs, climate variability, and market volatility are making disease prevention through vaccination more attractive than curative or culling-based approaches.

What Is Fueling Global Expansion of the Livestock Vaccines Market?

The growth in the livestock vaccines market is driven by several converging macroeconomic, technological, and policy factors. One of the most prominent drivers is the structural shift in global food systems toward protein-rich diets and intensive animal farming. This transition is particularly visible in Asia, Latin America, and parts of Africa, where rising incomes and urbanization are spurring demand for poultry, beef, and dairy products. To meet these demands sustainably, producers are investing in vaccination programs that reduce mortality, enhance feed efficiency, and improve overall herd productivity.

Government-sponsored mass vaccination programs, pandemic preparedness strategies, and donor-supported veterinary outreach in low- and middle-income countries are further expanding vaccine coverage and demand. Initiatives by organizations such as the FAO and World Bank to build veterinary infrastructure and disease monitoring systems are also increasing regional readiness for vaccine adoption. Digital animal health platforms are supporting vaccine tracking, adverse event reporting, and cold chain monitoring, while mobile-based livestock health services are improving outreach to smallholders and nomadic pastoralists.

Private sector engagement is also rising. Animal health divisions of multinational pharmaceutical firms are expanding vaccine portfolios, acquiring local manufacturers, and investing in regional R&D centers. In parallel, startup activity around synthetic biology and microbiome-enhanced vaccines is opening new frontiers in species-specific and precision immunization. As these forces continue to interact, the global livestock vaccines market is poised to grow not only in size but in strategic relevance, securing animal productivity, economic resilience, and public health security alike.

SCOPE OF STUDY:

The report analyzes the Livestock Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, Other Vaccine Types); Technology (Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology, Other Technologies); Administration Route (Oral Administration Route, Parenteral Administration Route, Other Routes of Administration); End-User (Veterinary Hospitals End-User, Veterinary Clinics End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• ADL Bionatur Solutions, S.A.
• AniCon Labor GmbH
• Animal Science Products Inc.
• Bayer AG
• Bimeda Biologicals
• Biogenesis Bago
• Boehringer Ingelheim Animal Health
• Calier
• Cargill Incorporated
• Ceva Sante Animale
• China Animal Husbandry Industry Co.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health
• Hester Biosciences Limited
• HIPRA
• Indovax
• Merck Animal Health
• Neogen Corporation
• Phibro Animal Health Corporation
• Zoetis Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Livestock Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Demand for Protein-Rich Diets Drives Vaccination in Livestock Production
  • Expansion of Commercial Animal Farming Throws the Spotlight on Preventive Veterinary Care
  • Outbreaks of Zoonotic Diseases Propel Growth in Mass Livestock Immunization Campaigns
  • Government-Led Livestock Immunization Programs Strengthen Market Accessibility in Rural Areas
  • Advancements in Recombinant and Vector-Based Vaccines Enhance Efficacy and Duration
  • Growing Emphasis on Antimicrobial Stewardship Spurs Shift Toward Preventive Vaccination
  • Expansion of Cold Chain Infrastructure Improves Vaccine Distribution in Developing Regions
  • Increased Surveillance and Disease Reporting Accelerates Prophylactic Vaccine Uptake
  • Integration of Digital Herd Health Monitoring Supports Targeted Vaccine Scheduling
  • Emergence of Multivalent and Thermostable Vaccines Simplifies Logistics and Boosts Compliance
  • Genetic Advancements in Animal Breeding Create Demand for Tailored Vaccine Solutions
  • Surging Investment in Animal Health Startups Expands R&D Pipelines in Livestock Immunology
  • Trade Regulations and Animal Export Standards Drive Compulsory Vaccination Protocols
  • Growth in Aquaculture and Poultry Segments Expands Use of Specialized Vaccination Programs
  • Improved Awareness Among Farmers Enhances Vaccination Coverage and Market Penetration
  • Increased Focus on Wildlife and Cross-Species Disease Control Spurs Novel Vaccine Development
  • Private-Public Partnerships Fuel Global Livestock Disease Eradication Strategies
  • Pharma Consolidation and M&A Activity Strengthen Distribution Capabilities of Animal Vaccines
  • Globalization of Livestock Trade Intensifies Demand for Standardized Immunization Solutions
  • Veterinary Training and Extension Services Generate Informed Vaccine Adoption at Farm Level
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Livestock Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Livestock Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bovine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bovine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Bovine Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Poultry Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Poultry Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Poultry Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Porcine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Porcine Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Porcine Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Parenteral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Parenteral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Routes of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Routes of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Routes of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oral Administration Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Oral Administration Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Veterinary Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Veterinary Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Veterinary Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Veterinary Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Veterinary Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Veterinary Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Live Attenuated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Live Attenuated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Live Attenuated Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Inactivated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Inactivated Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Inactivated Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Recombinant Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Recombinant Vaccine Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Recombinant Vaccine Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Canada 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• JAPAN
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Japan 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• CHINA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: China 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• EUROPE
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Livestock Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Europe 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• FRANCE
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: France 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• GERMANY
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Germany 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Italy 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: UK 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Spain 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Russia 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Livestock Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Australia 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• INDIA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: India 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: South Korea 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Livestock Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Latin America 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Argentina 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Brazil 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Mexico 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Livestock Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Middle East 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Iran 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Israel 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: UAE 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030
• AFRICA
  • Livestock Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Livestock Vaccines by Vaccine Type - Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Livestock Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bovine Vaccine, Poultry Vaccine, Porcine Vaccine and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Livestock Vaccines by Administration Route - Parenteral Administration Route, Other Routes of Administration and Oral Administration Route Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Livestock Vaccines by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration Route, Other Routes of Administration and Oral Administration Route for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Livestock Vaccines by End-user - Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Livestock Vaccines by End-user - Percentage Breakdown of Value Sales for Veterinary Hospitals End-User, Veterinary Clinics End-User and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Livestock Vaccines by Technology - Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Africa 15-Year Perspective for Livestock Vaccines by Technology - Percentage Breakdown of Value Sales for Live Attenuated Vaccine Technology, Inactivated Vaccine Technology, Recombinant Vaccine Technology and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION